Full Text View
Tabular View
No Study Results Posted
Related Studies
Augmenting Language Therapy for Aphasia: Levodopa
This study has been completed.
Study NCT01429077   Information provided by Rehabilitation Institute of Chicago

First Received on August 2, 2011.   Last Updated on June 13, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nonfluent Aphasia
Stroke
Additional conditions recognized in this trial
Aphasia
Aphasia, Broca
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Communication Disorders
Language Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Speech Disorders
Vascular Diseases
Interventions listed in this trial
levodopa/carbidopa
Additional drug interventions recognized in this trial
Carbidopa
Levodopa
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Rehabilitation Institute of Chicago
U.S. Department of Education


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services